Neurocrine Biosciences, Inc <NBIX.O>: Truist Securities Raises Target Price to $200 From $155
NBIX•Related News
Intel invests EUR 5 billion to expand chip manufacturing at Ireland Leixlip campus
INTC•
Intel to upgrade, expand Irish manufacturing hub with $5.7 bln investment
INTC•
CACI wins Department of War contract to deploy SkyValor drone defense system at Southern Border
CACI•
China aims to spur consumption in first five-year blueprint
MCHI•
CEL-SCI launches Phase 3 confirmatory trial of Multikine in head and neck cancer
CVM•